AbbVie expands IBD pipeline with US$138 M Landos acquisition
USA—AbbVie, the sixth largest pharmaceutical company in sales and headquartered in North Chicago,...
Read More
Tag: AbbVie
AbbVie completes US$10.1 B ImmunoGen acquisition fortifying oncology pipeline
AbbVie completes US$10.1 B ImmunoGen acquisition fortifying oncology pipeline
Read More
AbbVie expands neurology focus with US$8.7 billion acquisition of Cerevel Therapeutics
USA — AbbVie, a global biopharmaceutical company, is making headlines again with its recent...
Read More
AbbVie’s Imbruvica sales face decline amidst uncertainty over pricing negotiations
USA — The introduction of BeiGene’s groundbreaking oral leukemia treatment, Brukinsa, has...
Read More
Amgen successfully completes US$27.8 billion acquisition of Horizon Therapeutics after FTC challenge
USA — Amgen has successfully concluded its ambitious US$27.8 billion acquisition of Horizon...
Read More
AbbVie’s oncology drug epcoritamab receives conditional regulatory approval in the UAE
UAE – AbbVie’s TEPKINLY (epcoritamab) has been given conditional regulatory approval by the...
Read More
Unraveling the complex world of biosimilars as battle for the lucrative US market intensifies
USA — The race to take on one of the most profitable drugs globally, AbbVie’s arthritis...
Read More
Biosimilar launches of expensive arthritis drug Humira spark scrutiny on drug pricing middlemen
USA —The world of arthritis treatments in the U.S. is witnessing a transformative shift as seven...
Read More
Drugmakers introduce cheaper alternatives to Humira, a blockbuster arthritis drug
USA — Drug manufacturers Organon and Samsung Bioepis have announced the launch of a lower-cost...
Read More
Lupin nabs an additional US$25M from AbbVie to accelerate its cancer drug trials
INDIA – Mumbai-based drug maker Lupin has scooped up an additional US$25 million from AbbVie to...
Read More
DoH, M42, and AbbVie unite to advance precision medicine, genomics in Abu Dhabi
UAE – The Department of Health – Abu Dhabi (DoH), AbbVie Biopharmaceutical, and M42 have formed a...
Read More
AbbVie misses quarterly revenue, spurring concerns over future sales amid Humira competition
USA —AbbVie Inc has missed quarterly revenue estimates for its newer treatments, causing concerns...
Read More
LATEST DIGITAL MAGAZINE
